255 related articles for article (PubMed ID: 17680360)
1. Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease.
Ribeiro CA; Sgaravatti AM; Rosa RB; Schuck PF; Grando V; Schmidt AL; Ferreira GC; Perry ML; Dutra-Filho CS; Wajner M
Neurochem Res; 2008 Jan; 33(1):114-24. PubMed ID: 17680360
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease.
Sgaravatti AM; Rosa RB; Schuck PF; Ribeiro CA; Wannmacher CM; Wyse AT; Dutra-Filho CS; Wajner M
Biochim Biophys Acta; 2003 Nov; 1639(3):232-8. PubMed ID: 14636955
[TBL] [Abstract][Full Text] [Related]
3. Morphological alterations and cell death provoked by the branched-chain alpha-amino acids accumulating in maple syrup urine disease in astrocytes from rat cerebral cortex.
Funchal C; Gottfried C; de Almeida LM; dos Santos AQ; Wajner M; Pessoa-Pureur R
Cell Mol Neurobiol; 2005 Aug; 25(5):851-67. PubMed ID: 16133938
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.
Vilela TC; Scaini G; Furlanetto CB; Pasquali MA; Santos JP; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Streck EL
Metab Brain Dis; 2017 Feb; 32(1):115-122. PubMed ID: 27510712
[TBL] [Abstract][Full Text] [Related]
5. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
[TBL] [Abstract][Full Text] [Related]
6. Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.
Streck EL; Bussular FP; Wessler LB; Duarte MB; Rezende VL; Rodrigues MS; Torres CA; Lemos IS; Candiotto G; Gava FF; de Oliveira J; Valvassori SS
Metab Brain Dis; 2021 Feb; 36(2):247-254. PubMed ID: 33098071
[TBL] [Abstract][Full Text] [Related]
7. Branched-chain amino acids (BCAA) administration increases autophagy and the autophagic pathway in brain tissue of rats submitted to a Maple Syrup Urine Disease (MSUD) protocol.
Fermo KT; da Silva Lemos I; Farias HR; Rosso MP; Effting PS; Leipnitz G; Streck EL
Metab Brain Dis; 2023 Jan; 38(1):287-293. PubMed ID: 36305998
[TBL] [Abstract][Full Text] [Related]
8. A chemically-induced acute model of maple syrup urine disease in rats for neurochemical studies.
Bridi R; Fontella FU; Pulrolnik V; Braun CA; Zorzi GK; Coelho D; Wajner M; Vargas CR; Dutra-Filho CS
J Neurosci Methods; 2006 Sep; 155(2):224-30. PubMed ID: 16530844
[TBL] [Abstract][Full Text] [Related]
9. Kinetic studies on the inhibition of creatine kinase activity by branched-chain alpha-amino acids in the brain cortex of rats.
Pilla C; Cardozo RF; Dornelles PK; Dutra-Filho CS; Wyse AT; Wajner M; Wannmacher CM
Int J Dev Neurosci; 2003 May; 21(3):145-51. PubMed ID: 12711352
[TBL] [Abstract][Full Text] [Related]
10. Intrahippocampal administration of the branched-chain alpha-hydroxy acids accumulating in maple syrup urine disease compromises rat performance in aversive and non-aversive behavioral tasks.
Vasques Vde C; Brinco F; Wajner M
J Neurol Sci; 2005 May; 232(1-2):11-21. PubMed ID: 15850577
[TBL] [Abstract][Full Text] [Related]
11. Branched-Chain Amino Acids and Brain Metabolism.
Sperringer JE; Addington A; Hutson SM
Neurochem Res; 2017 Jun; 42(6):1697-1709. PubMed ID: 28417264
[TBL] [Abstract][Full Text] [Related]
12. Evidence that the branched-chain alpha-keto acids accumulating in maple syrup urine disease induce morphological alterations and death in cultured astrocytes from rat cerebral cortex.
Funchal C; Gottfried C; De Almeida LM; Wajner M; Pessoa-Pureur R
Glia; 2004 Nov; 48(3):230-40. PubMed ID: 15390119
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.
Amaral AU; Wajner M
Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033
[TBL] [Abstract][Full Text] [Related]
14. Synaptic plasma membrane Na(+), K (+)-ATPase activity is significantly reduced by the alpha-keto acids accumulating in maple syrup urine disease in rat cerebral cortex.
Wajner A; Bürger C; Dutra-Filho CS; Wajner M; de Souza Wyse AT; Wannmacher CM
Metab Brain Dis; 2007 Mar; 22(1):77-88. PubMed ID: 17295076
[TBL] [Abstract][Full Text] [Related]
15. Functional differences in the catabolism of branched-chain L-amino acids in cultured normal and maple syrup urine disease fibroblasts.
Schadewaldt P; Wendel U
Biochem Med Metab Biol; 1989 Apr; 41(2):105-16. PubMed ID: 2719855
[TBL] [Abstract][Full Text] [Related]
16. Creatine kinase activity from rat brain is inhibited by branched-chain amino acids in vitro.
Pilla C; Cardozo RF; Dutra-Filho CS; Wyse AT; Wajner M; Wannmacher CM
Neurochem Res; 2003 May; 28(5):675-9. PubMed ID: 12716015
[TBL] [Abstract][Full Text] [Related]
17. Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease.
Bridi R; Araldi J; Sgarbi MB; Testa CG; Durigon K; Wajner M; Dutra-Filho CS
Int J Dev Neurosci; 2003 Oct; 21(6):327-32. PubMed ID: 12927581
[TBL] [Abstract][Full Text] [Related]
18. Branched-chain amino acids accumulating in maple syrup urine disease induce morphological alterations in C6 glioma cells probably through reactive species.
de Lima Pelaez P; Funchal C; Loureiro SO; Heimfarth L; Zamoner A; Gottfried C; Latini A; Wajner M; Pessoa-Pureur R
Int J Dev Neurosci; 2007 May; 25(3):181-9. PubMed ID: 17317075
[TBL] [Abstract][Full Text] [Related]
19. Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells.
Funchal C; Tramontina F; Quincozes dos Santos A; Fraga de Souza D; Gonçalves CA; Pessoa-Pureur R; Wajner M
J Neurol Sci; 2007 Sep; 260(1-2):87-94. PubMed ID: 17499767
[TBL] [Abstract][Full Text] [Related]
20. Coadministration of tianeptine alters behavioral parameters and levels of neurotrophins in a chronic model of Maple Syrup Urine disease.
Morais FA; Lemos IS; Matiola RT; Freitas MLS; Alano CG; Cabral J; Wessler LB; Generoso JS; Scaini G; Réus GZ; Streck EL
Metab Brain Dis; 2022 Jun; 37(5):1585-1596. PubMed ID: 35394251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
